Article
Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation.
Brain tumor pathology - 1 Jul 2014
Tanaka Shingo, Nakada Mitsutoshi, Nobusawa Sumihito, Suzuki Satoshi O, Sabit Hemragul, Miyashita Katsuyoshi, Hayashi Yutaka
Abstract excerpt
Pleomorphic xanthoastrocytoma (PXA) is classified by the World Health Organization as a grade II astrocytic tumor with relatively favorable prognosis among gliomas. A valine-to-glutamic acid substitution at position 600 of the serine/threonine-protein kinase BRAF (BRAF V600E) mutation, which is commonly found in PXA, has recently been detected in approximately 50% of all epithelioid glioblastoma (GBM) cases. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
